BMS-1001 is an orally active human PD-L1/PD-1 immune checkpoint inhibitor. BMS-1001 exhibits low-toxicity in cells. The IC50 value of BMS-1001 in a homogeneous time-resolved fluorescence (HTRF) binding assay is 2.25 nM[1][2].
Molecular Weight:
631.11
Purity:
98.01
CAS Number:
[2113650-04-5]
Formula:
C35H35ClN2O7
Target:
PD-1/PD-L1
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted